News

Our Healthcare News

Grupo Biotoscana Advances Integration of Laboratorio LKM

MONTEVIDEO – – Grupo Biotoscana SL (GBT), a leading specialty pharmaceutical company in Latin America, today announced continued progress in its integration of Laboratorio LKM…  

Feb 04 2016

Abiomed Announces Q3 FY 2016 Revenue of $85.8 Million, Up 38% Over Prior Year

DANVERS, Massachusetts—Abiomed (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today reported third quarter fiscal 2016 revenue of $85.8 million, an increase of…  

Feb 04 2016

Endologix, Inc. and TriVascular Technologies, Inc. Complete Merger

IRVINE, California (GLOBE NEWSWIRE)—Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has successfully completed the previously announced…  

Feb 03 2016

Abiomed Announces Preliminary Q3 FY 2016 Revenue of $85.8 Million, Up 38% Over Prior Year

SAN FRANCISCO, CA.—Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today reported preliminary unaudited third quarter fiscal 2016 revenue of approximately…  

Jan 11 2016

Baxalta and Symphogen Establish Strategic Collaboration to Accelerate Innovation in Immuno-Oncology

BANNOCKBURN, Ill. and COPENHAGEN, Denmark – Baxalta Incorporated (NYSE: BXLT), a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and…  

Jan 04 2016

Grupo Biotoscana acquires Laboratorio LKM

MADRID AND BUENOS AIRES – Grupo Biotoscana SL, a leading specialty pharmaceutical company in Latin America, today announced that it has completed the acquisition of…  

Dec 21 2015

Ligand to Acquire OMT, Inc., a Leader in Human Antibody Generation, for $178 Million in Cash & Stock

SAN DIEGO & PALO ALTO, California—Ligand Pharmaceuticals Incorporated (NASDAQ:  LGND) and OMT, Inc. (Open Monoclonal Technology) announce the signing of agreements for Ligand to acquire…  

Dec 17 2015

Molecular Partners Received a European Small and Mid-Cap Award

ZURICH-SCHLIEREN, Switzerland—Molecular Partners AG (MOLN) announced today that the company has achieved a top 3 ranking in the category “Most Innovative Newcomer” at the Euro-pean…  

Dec 09 2015

Elusys Therapeutics Receives First Delivery Order from US Government for Anthim

PINE BROOK, New Jersey – Elusys Therapeutics, Inc. (Elusys) today announced it has been awarded its first delivery order under a procurement contract for Anthim…  

Nov 12 2015